Remyelination After Cuprizone-Induced Demyelination Is Accelerated in Juvenile Mice

Journal of Neuropathology and Experimental Neurology

Volumn 74, Issue 8, 2015, Pages 756-766

  Pfeifenbring, Sabine ^a   Nessler, Stefan ^a   Wegner, Christiane ^a   Stadelmann, Christine ^a   Brück, Wolfgang ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

Cuprizone; Demyelination; Juvenile mice; Pediatric multiple sclerosis; Remyelination

Indexed keywords

CUPRIZONE; MYELIN; MONOAMINE OXIDASE INHIBITOR;

ADULT; ANIMAL TISSUE; ARTICLE; ASTROCYTOSIS; AXONAL INJURY; BRAIN MATURATION; CELL ACTIVATION; CELL PROLIFERATION; COMPARATIVE STUDY; CONTROLLED STUDY; CORPUS CALLOSUM; DEMYELINATION; ELECTRON MICROSCOPY; GRAY MATTER; HISTOLOGY; IMMUNOHISTOCHEMISTRY; JUVENILE; MICROGLIA; MOTOR CORTEX; MOUSE; NONHUMAN; OLIGODENDROCYTE PRECURSOR CELL; OLIGODENDROGLIA; PRIORITY JOURNAL; REMYELINIZATION; TREATMENT DURATION; WHITE MATTER; AGING; ANIMAL; BRAIN; C57BL MOUSE; CHEMICALLY INDUCED; DEMYELINATING DISEASE; DISEASE MODEL; NERVE REGENERATION; PATHOLOGY; PHYSIOLOGY; TRANSMISSION ELECTRON MICROSCOPY;

AGING; ANIMALS; BRAIN; CUPRIZONE; DEMYELINATING DISEASES; DISEASE MODELS, ANIMAL; IMMUNOHISTOCHEMISTRY; MICE; MICE, INBRED C57BL; MICROSCOPY, ELECTRON, TRANSMISSION; MONOAMINE OXIDASE INHIBITORS; NERVE REGENERATION; OLIGODENDROGLIA;

EID: 84938519804     PISSN: 00223069     EISSN: 15546578     Source Type: Journal    
DOI: 10.1097/NEN.0000000000000214     Document Type: Article

References (61)

1. Brück W, Porada P, Poser S, et al. Monocyte/macrophage differentiation in early multiple sclerosis lesions. Ann Neurol 1995;38:788-96
2. Kutzelnigg A, Lucchinetti CF, Stadelmann C, et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 2005; 128:2705-12
3. Kutzelnigg A, Faber-Rod JC, Bauer J, et al. Widespread demyelination in the cerebellar cortex in multiple sclerosis. Brain Pathol 2007;17:38-44
4. Bø L, Vedeler CA, Nyland HI, Trapp BD, MLrk SJ. Subpial demyelination in the cerebral cortex of multiple sclerosis patients. J Neuropathol Exp Neurol 2003;62:723-32
5. Lucchinetti CF, Popescu BF, Bunyan RF, et al. Inflammatory cortical demyelination in early multiple sclerosis. N Engl J Med 2011;365:2188-97
6. Kidd D, Barkhof F, McConnell R, Algra PR, Allen IV, Revesz T. Cortical lesions in multiple sclerosis. Brain 1999;122:17-26
7. Geurts JJ, Barkhof F. Grey matter pathology in multiple sclerosis. Lancet Neurol 2008;7:841-51
8. Brück W, Schmied M, Suchanek G, et al. Oligodendrocytes in the early course of multiple sclerosis. Ann Neurol 1994;35:65-73
9. Goldschmidt T, Antel J, König FB, Brück W, Kuhlmann T. Remyelination capacity of the MS brain decreases with disease chronicity. Neurology 2009;72:1914-21
10. Albert M, Antel J, Brück W, Stadelmann C. Extensive cortical remyelination in patients with chronic multiple sclerosis. Brain Pathol 2007;17: 129-38
11. Chang A, Staugaitis SM, Dutta R, et al. Cortical remyelination: A new target for repair therapies in multiple sclerosis. Ann Neurol 2012;72: 918-26
12. Banwell B, Ghezzi A, Bar-Or A, Mikaeloff Y, Tardieu M. Multiple sclerosis in children: Clinical diagnosis, therapeutic strategies, and future directions. Lancet Neurol 2007;6:887-902
13. Fay AJ, Mowry EM, Strober J, Waubant E. Relapse severity and recovery in early pediatric multiple sclerosis. Mult Scler 2012;18:1008-12
14. Cossburn M, Ingram G, Hirst C, Ben-Shlomo Y, Pickersgill TP, Robertson NP. Age at onset as a determinant of presenting phenotype and initial relapse recovery in multiple sclerosis. Mult Scler 2012;18:45-54
15. Yeh EA, Chitnis T, Krupp L; US Network of Pediatric Multiple Sclerosis Centers of Excellence. Pediatric multiple sclerosis. Nat Rev Neurol 2009; 5:621-31
16. Gadoth N. Multiple sclerosis in children. Brain Dev 2003;25:229-32
17. Chabas D, Strober J, Waubant E. Pediatric multiple sclerosis. Curr Neurol Neurosci Rep 2008;8:434-41
18. Waubant E, Chabas D. Pediatric multiple sclerosis. Curr Treat Options Neurol 2009;11:203-10
19. Franklin RJ, Zhao C, Sim FJ. Ageing and CNS remyelination. Neuroreport 2002;13:923-28
20. Kriss A, Francis DA, Cuendet F, et al. Recovery after optic neuritis in childhood. J Neurol Neurosurg Psychiatry 1988;51:1253-58
21. Bavelier D, Levi DM, Li RW, Dan Y, Hensch TK. Removing brakes on adult brain plasticity: From molecular to behavioral interventions. J Neurosci 2010;30:14964-71
22. Johnston MV. Plasticity in the developing brain: Implications for rehabilitation. Dev Disabil Res Rev 2009;15:94-101
23. Brown RA, Narayanan S, Banwell B, Arnold DL; Canadian Pediatric Demyelinating Disease Network. Magnetization transfer ratio recovery in new lesions decreases during adolescence in pediatric-onset multiple sclerosis patients. Neuroimage Clin 2014;6:237-42
24. Barkhof F, Bruck W, De Groot CJ, et al. Remyelinated lesions in multiple sclerosis: Magnetic resonance image appearance. Arch Neurol 2003;60: 1073-81
25. Sim FJ, Zhao C, Penderis J, Franklin RJ. The age-related decrease in CNS remyelination efficiency is attributable to an impairment of both oligodendrocyte progenitor recruitment and differentiation. J Neurosci 2002;22:2451-59
26. Zhao C, Li WW, Franklin RJ. Differences in the early inflammatory responses to toxin-induced demyelination are associated with the age-related decline in CNS remyelination. Neurobiol Aging 2006;27:1298-307
27. Shields SA, Gilson JM, Blakemore WF, Franklin RJ. Remyelination occurs as extensively but more slowly in old rats compared to young rats following gliotoxin-induced CNS demyelination. Glia 1999;28:77-83
28. Gilson J, Blakemore WF. Failure of remyelination in areas of demyelination produced in the spinal cord of old rats. Neuropathol Appl Neurobiol 1993;19:173-81
29. Doucette JR, Jiao R, Nazarali AJ. Age-related and cuprizone-induced changes in myelin and transcription factor gene expression and in oligodendrocyte cell densities in the rostral corpus callosum of mice. Cell Mol Neurobiol 2010;30:607-29
30. Shen S, Sandoval J, Swiss VA, et al. Age-dependent epigenetic control of differentiation inhibitors is critical for remyelination efficiency. Nat Neurosci 2008;11:1024-34
31. Ludwin SK. Central nervous system demyelination and remyelination in the mouse: An ultrastructural study of cuprizone toxicity. Lab Invest 1978;39:597-612
32. Blakemore WF. Remyelination of the superior cerebellar peduncle in the mouse following demyelination induced by feeding cuprizone. J Neurol Sci 1973;20:73-83
33. Makinodan M, Yamauchi T, Tatsumi K, et al. Demyelination in the juvenile period, but not in adulthood, leads to long-lasting cognitive impairment and deficient social interaction in mice. Prog Neuropsychopharmacol Biol Psychiatry 2009;33:978-85
34. Kipp M, Clarner T, Dang J, Copray S, Beyer C. The cuprizone animal model: New insights into an old story. Acta Neuropathol 2009;118: 723-36
35. Matsushima GK, Morell P. The neurotoxicant, cuprizone, as a model to study demyelination and remyelination in the central nervous system. Brain Pathol 2001;11:107-16
36. Blakemore WF. Demyelination of the superior cerebellar peduncle in the mouse induced by cuprizone. J Neurol Sci 1973;20:63-72
37. Skripuletz T, Gudi V, Hackstette D, Stangel M. De-and remyelination in the CNS white and grey matter induced by cuprizone: The old, the new, and the unexpected. Histol Histopathol 2011;26:1585-97
38. Skripuletz T, Lindner M, Kotsiari A, et al. Cortical demyelination is prominent in the murine cuprizone model and is strain-dependent. Am J Pathol 2008;172:1053-61
39. Skripuletz T, Bussmann JH, Gudi V, et al. Cerebellar cortical demyelination in the murine cuprizone model. Brain Pathol 2010;20:301-12
40. Gudi V, Moharregh-Khiabani D, Skripuletz T, et al. Regional differences between grey and white matter in cuprizone induced demyelination. Brain Res 2009;1283:127-38
41. Lindner M, Heine S, Haastert K, et al. Sequential myelin protein expression during remyelination reveals fast and efficient repair after central nervous system demyelination. Neuropathol Appl Neurobiol 2008; 34:105-14
42. Franklin KBJ, Paxinos G. The Mouse Brain in Stereotaxic Coordinates. New York, NY: Academic Press, 1997
43. Oertle T, van der Haar ME, Bandtlow CE, et al. Nogo-A inhibits neurite outgrowth and cell spreading with three discrete regions. J Neurosci 2003; 23:5393-406
44. Gudi V, Škuljec J, Yildiz Ö, et al. Spatial and temporal profiles of growth factor expression during CNS demyelination reveal the dynamics of repair priming. PLoS One 2011;6:e22623
45. Kuhlmann T, Miron V, Cui Q, Wegner C, Antel J, Brück W. Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis. Brain 2008;131:1749-58
46. Richardson KC, Jarett L, Finke EH. Embedding in epoxy resins for ultrathin sectioning in electron microscopy. Stain Technol 1960;35:313-23
47. Franklin RJ, Ffrench-Constant C. Remyelination in the CNS: From biology to therapy. Nat Rev Neurosci 2008;9:839-55
48. Kuhlmann T, Lingfeld G, Bitsch A, Schuchardt J, Brück W. Acute axonal damage in multiple sclerosis is most extensive in early disease stages and decreases over time. Brain 2002;125:2202-12
49. Wang H, Li C, Wang H, et al. Cuprizone-induced demyelination in mice: Age-related vulnerability and exploratory behavior deficit. Neurosci Bull 2013;29:251-59
50. Yakovlev AG, Ota K, Wang G, et al. Differential expression of apoptotic protease-activating factor-1 and caspase-3 genes and susceptibility to apoptosis during brain development and after traumatic brain injury. J Neurosci 2001;21:7439-46
51. Polster BM, Robertson CL, Bucci CJ, Suzuki M, Fiskum G. Postnatal brain development and neural cell differentiation modulate mitochondrial Bax and BH3 peptide Yinduced cytochrome c release. Cell Death Differ 2003;10:365-70
52. Kalous M, Drahota Z. The role of mitochondria in aging. Physiol Res 1996;45:351-59
53. Baer AS, Syed YA, Kang SU, et al. Myelin-mediated inhibition of oligodendrocyte precursor differentiation can be overcome by pharmacological modulation of Fyn-RhoA and protein kinase C signalling. Brain 2009;132:465-81
54. Kotter MR, Li WW, Zhao C, Franklin RJ. Myelin impairs CNS remyelination by inhibiting oligodendrocyte precursor cell differentiation. J Neurosci 2006;26:328-32
55. Robinson S, Miller RH. Contact with central nervous system myelin inhibits oligodendrocyte progenitor maturation. Dev Biol 1999;216: 359-68
56. Hinks GL, Franklin RJ. Delayed changes in growth factor gene expression during slow remyelination in the CNS of aged rats. Mol Cell Neurosci 2000;16:542-56
57. Ruckh JM, Zhao JW, Shadrach JL, et al. Rejuvenation of regeneration in the aging central nervous system. Cell Stem Cell 2012;10:96-103
58. Irvine KA, Blakemore WF. Age increases axon loss associated with primary demyelination in cuprizone-induced demyelination in C57BL/6 mice. J Neuroimmunol 2006;175:69-76
59. Roessmann U, Gambetti P. Astrocytes in the developing human brain. An immunohistochemical study. Acta Neuropathol 1986;70:308-13
60. Fulcrand J, Valat J, Privat A. [Myelination gliosis and reactive gliosis in the developing optic nerve of the rat]. Reprod Nutr Dev 1982;22:171-78
61. Rozovsky I, Finch CE, Morgan TE. Age-related activation of microglia and astrocytes: In vitro studies show persistent phenotypes of aging, increased proliferation, and resistance to down-regulation. Neurobiol Aging 1998;19:97-103